Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

Survival Benefits From Metformin Use in Pancreatic Cancer

Survival Benefits From Metformin Use in Pancreatic Cancer Pancreas Volume 47, Number 3, March 2018 Letters to the Editor multicenter survey. Endoscopy.2007;39: 4 cases of pancreatitis (1.98%). In these P = 0.01) (Fig. 1). The statistical hetero- 613–615. cases, the admission length of stay was 4, geneity was moderate with I of 58% 7, 14, and 15 days. This subgroup of patients (P = 0.02). 7. Möschler O, May A, Müller MK, et al. heterogeneity with pancreatitis had a significantly longer Theoretically, metformin was found Complications in and performance of inpatient stay than that noted by Wadhwa double-balloon enteroscopy (DBE): results to have antineoplastic properties through et al. Therefore, perhaps further study is re- from a large prospective DBE database in several mechanisms in in vitro studies. Germany. Endoscopy. 2011;43:484–489. quired in understanding the length of stay in Pancreatic cancer cells are supposedly hospital and therefore cost by subdividing stimulated by insulin-like growth factor 8. Jovanovic I, Vormbrock K, Zimmermann L, pancreatitis by etiology. et al. Therapeutic double-balloon enteroscopy: 1(IGF-1). Whole body production and In conclusion, DBE is an iatrogenic a binational, three-center experience. Dig Dis. sensitivity of IGF-1 are increased by cause of acute pancreatitis. It is of interest 2011;29(suppl 1):27–31. hyperinsulinemic states. Metformin decreases that http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Pancreas Wolters Kluwer Health

Survival Benefits From Metformin Use in Pancreatic Cancer

Download PDF
4 pages

Loading next page...
 
/lp/wolters_kluwer/survival-benefits-from-metformin-use-in-pancreatic-cancer-MwvIO9rElS

References (13)

Publisher
Wolters Kluwer Health
Copyright
Copyright © 2018 Wolters Kluwer Health, Inc. All rights reserved.
ISSN
0885-3177
eISSN
1536-4828
DOI
10.1097/MPA.0000000000001000
pmid
29424813
Publisher site
See Article on Publisher Site

Abstract

Pancreas Volume 47, Number 3, March 2018 Letters to the Editor multicenter survey. Endoscopy.2007;39: 4 cases of pancreatitis (1.98%). In these P = 0.01) (Fig. 1). The statistical hetero- 613–615. cases, the admission length of stay was 4, geneity was moderate with I of 58% 7, 14, and 15 days. This subgroup of patients (P = 0.02). 7. Möschler O, May A, Müller MK, et al. heterogeneity with pancreatitis had a significantly longer Theoretically, metformin was found Complications in and performance of inpatient stay than that noted by Wadhwa double-balloon enteroscopy (DBE): results to have antineoplastic properties through et al. Therefore, perhaps further study is re- from a large prospective DBE database in several mechanisms in in vitro studies. Germany. Endoscopy. 2011;43:484–489. quired in understanding the length of stay in Pancreatic cancer cells are supposedly hospital and therefore cost by subdividing stimulated by insulin-like growth factor 8. Jovanovic I, Vormbrock K, Zimmermann L, pancreatitis by etiology. et al. Therapeutic double-balloon enteroscopy: 1(IGF-1). Whole body production and In conclusion, DBE is an iatrogenic a binational, three-center experience. Dig Dis. sensitivity of IGF-1 are increased by cause of acute pancreatitis. It is of interest 2011;29(suppl 1):27–31. hyperinsulinemic states. Metformin decreases that

Journal

Pancreas – Wolters Kluwer Health

Published: Jan 1, 2018

There are no references for this article.